This week is the last week of 2021. Looking back on the new share market in 2021, a total of 524 listed companies have successfully “flushed a” this year, with a total fund-raising of 543.773.2 billion yuan. Both data set a historical record .
a total of 9 new shares were listed this week. According to xingkuang’s data, the average increase of new shares listed this week on the first day was 19.21% . There was no break on the first day last week. The rise and fall of four new shares relative to the issue price on the first day of listing this week was negative.
Based on the closing price of the first day, the companies with single sign profit and loss on the first day include Nanmo biology, oni electronics, Pingao Co., Ltd. and Chunli medical, among them, Nanmo biology has the highest loss, with a single sign loss of 7626 yuan. The company with the highest single sign profit earned 9490 yuan per day, the company with no income of more than 10000 yuan on the first day of this week has a relatively light market at the end of the year.
Youningwei, the company with the highest profit this week, is a large agent of life science reagents in China. The company has accumulated a wide range of high-quality customer groups, such as Qingbei Fujiao, Chinese Academy of Sciences, Wuxi Apptec Co.Ltd(603259) , Zhongshan Hospital Affiliated to Fudan University, etc; What needs to be vigilant is that the company currently relies on third-party brands and basically has no independent production. Nanmo biology, the company with the highest loss this week, is the leader in the field of model animals in China backed by the Chinese Academy of Sciences and the first in China in the field of customized models and model breeding and feeding.
as a company listed on Tuesday (December 28), the issue price difference is less than 2 yuan. As a cooperative company of well-known universities, well-known hospitals and well-known innovative drug R & D companies, why is the income difference so great? it is worth noting that the issuance P / E ratio of yuningwei is 104.09, which is far lower than the average p / E ratio of comparable companies given in the prospectus; The issuance P / E ratio of Nanmo biology is 201.59, which is much higher than that of comparable companies.
This week (from December 27 to December 31), the performance of 9 new shares after listing is shown in the table below:
(Financial Associated Press)
